Literature DB >> 19458888

Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.

N Pischon1, J M Mäki, P Weisshaupt, N Heng, A H Palamakumbura, P N'Guessan, A Ding, R Radlanski, H Renz, T A L J J Bronckers, J Myllyharju, A M Kielbassa, B M Kleber, J-P Bernimoulin, P C Trackman.   

Abstract

Lysyl oxidase (LOX) catalyzes cross-linking of elastin and collagen, which is essential for the structural integrity and function of bone tissue. The present study examined the role of Lox gene deficiency for the osteoblast phenotype in primary calvarial osteoblasts from E18.5 Lox knockout (Lox ( -/- )) and wild type (wt) (C57BL/6) mice. Next to Lox gene depletion, mRNA expression of Lox isoforms, LOXL1-4, was significantly downregulated in Lox ( -/- ) bone tissue. A significant decrease of DNA synthesis of Lox ( -/- ) osteoblasts compared to wt was found. Early stages of osteoblastic apoptosis studied by annexin-V binding as well as later stages of DNA fragmentation were not affected. However, mineral nodule formation and osteoblastic differentiation were markedly decreased, as revealed by significant downregulation of osteoblastic markers, type I collagen, bone sialoprotein, and Runx2/Cbfa1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458888      PMCID: PMC2827261          DOI: 10.1007/s00223-009-9252-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  42 in total

1.  A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25.

Authors:  K Kenyon; W S Modi; S Contente; R M Friedman
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

2.  Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations.

Authors:  C G Bellows; J E Aubin; J N Heersche; M E Antosz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

Review 3.  Properties and function of lysyl oxidase.

Authors:  H M Kagan; P C Trackman
Journal:  Am J Respir Cell Mol Biol       Date:  1991-09       Impact factor: 6.914

4.  Biochemical changes in the collagenous matrix of osteoporotic avian bone.

Authors:  L Knott; C C Whitehead; R H Fleming; A J Bailey
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

5.  Expression and purification of enzymatically active forms of the human lysyl oxidase-like protein 4.

Authors:  Moon Suk Kim; Sung-Su Kim; Sang Taek Jung; Jung-Young Park; Han-Wook Yoo; Jesang Ko; Katalin Csiszar; Sang-Yun Choi; Youngho Kim
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

6.  The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.

Authors:  Amitha H Palamakumbura; Sébastien Jeay; Ying Guo; Nicole Pischon; Pascal Sommer; Gail E Sonenshein; Philip C Trackman
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

7.  Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts.

Authors:  Nicole Pischon; Laurent M Darbois; Amitha H Palamakumbura; Efrat Kessler; Philip C Trackman
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

8.  Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues.

Authors:  D R Eyre; I R Dickson; K Van Ness
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

9.  Prenatal development of the human mandible. 3D reconstructions, morphometry and bone remodelling pattern, sizes 12-117 mm CRL.

Authors:  Ralf J Radlanski; Herbert Renz; Marie C Klarkowski
Journal:  Anat Embryol (Berl)       Date:  2003-09-10

10.  Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture.

Authors:  B Ecarot-Charrier; F H Glorieux; M van der Rest; G Pereira
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  23 in total

1.  Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype.

Authors:  Valerie S Salazar; Nicholas Zarkadis; Lisa Huang; Jin Norris; Susan K Grimston; Gabriel Mbalaviele; Roberto Civitelli
Journal:  J Cell Sci       Date:  2013-09-04       Impact factor: 5.285

2.  Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts.

Authors:  Debika Mitra; Osamu W Yasui; Jenna N Harvestine; Jarrett M Link; Jerry C Hu; Kyriacos A Athanasiou; J Kent Leach
Journal:  Biotechnol J       Date:  2018-08-16       Impact factor: 4.677

3.  Association of Bone Mineral Density With the Risk of Intracranial Aneurysm.

Authors:  Yong-Won Shin; Kyung-Il Park; Jangsup Moon; Soon-Tae Lee; Kon Chu; Sang Kun Lee; Jae-Kyu Roh; Keun-Hwa Jung
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 4.  Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.

Authors:  Nikolaos Papadantonakis; Shinobu Matsuura; Katya Ravid
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

5.  Characterization of recombinant lysyl oxidase propeptide.

Authors:  Siddharth R Vora; Ying Guo; Danielle N Stephens; Erdjan Salih; Emile D Vu; Kathrin H Kirsch; Gail E Sonenshein; Philip C Trackman
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

6.  Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.

Authors:  John H Hutchinson; Martin W Rowbottom; David Lonergan; Janice Darlington; Pat Prodanovich; Christopher D King; Jilly F Evans; Gretchen Bain
Journal:  ACS Med Chem Lett       Date:  2017-03-01       Impact factor: 4.345

7.  Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone.

Authors:  Nicoletta Bivi; Mark T Nelson; Meghan E Faillace; Jiliang Li; Lisa M Miller; Lilian I Plotkin
Journal:  Calcif Tissue Int       Date:  2012-08-04       Impact factor: 4.333

8.  Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.

Authors:  Siddharth R Vora; Amitha H Palamakumbura; Maria Mitsi; Ying Guo; Nicole Pischon; Matthew A Nugent; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

Review 9.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

Review 10.  Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone.

Authors:  Philip C Trackman
Journal:  Matrix Biol       Date:  2016-01-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.